BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32570581)

  • 1. Association of C>U RNA Editing with Human Disease Variants.
    Mandloi S; Falls Z; Deng R; Samudrala R; Elkin PL
    Stud Health Technol Inform; 2020 Jun; 270():1205-1206. PubMed ID: 32570581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The implications of APOBEC3-mediated C-to-U RNA editing for human disease.
    Van Norden M; Falls Z; Mandloi S; Segal BH; Baysal BE; Samudrala R; Elkin PL
    Commun Biol; 2024 May; 7(1):529. PubMed ID: 38704509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
    Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
    J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide identification and functional analysis of Apobec-1-mediated C-to-U RNA editing in mouse small intestine and liver.
    Blanc V; Park E; Schaefer S; Miller M; Lin Y; Kennedy S; Billing AM; Ben Hamidane H; Graumann J; Mortazavi A; Nadeau JH; Davidson NO
    Genome Biol; 2014 Jun; 15(6):R79. PubMed ID: 24946870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family.
    Liao W; Hong SH; Chan BH; Rudolph FB; Clark SC; Chan L
    Biochem Biophys Res Commun; 1999 Jul; 260(2):398-404. PubMed ID: 10403781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.
    Dance GS; Beemiller P; Yang Y; Mater DV; Mian IS; Smith HC
    Nucleic Acids Res; 2001 Apr; 29(8):1772-80. PubMed ID: 11292850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP; Eagleton MJ; Smith HC
    Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.
    Chester A; Scott J; Anant S; Navaratnam N
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):1-13. PubMed ID: 11072063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.
    Jarmuz A; Chester A; Bayliss J; Gisbourne J; Dunham I; Scott J; Navaratnam N
    Genomics; 2002 Mar; 79(3):285-96. PubMed ID: 11863358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.
    Fossat N; Tam PP
    RNA Biol; 2014; 11(10):1233-7. PubMed ID: 25585043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
    Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
    EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC-1-mediated RNA editing.
    Blanc V; Davidson NO
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(5):594-602. PubMed ID: 20836050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of C-to-U RNA editing using an artificial MS2-APOBEC system.
    Li J; Fan G; Sakari M; Tsukahara T
    Biotechnol J; 2024 Jan; 19(1):e2300321. PubMed ID: 38010373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.
    Fujino T; Navaratnam N; Jarmuz A; von Haeseler A; Scott J
    Nucleic Acids Res; 1999 Jul; 27(13):2662-71. PubMed ID: 10373583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
    Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
    J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.